{"id":"abi-injection","safety":{"commonSideEffects":[{"rate":"1-5%","effect":"Cardiac tamponade"},{"rate":"1-5%","effect":"Pneumothorax"},{"rate":"1-5%","effect":"Pericardial effusion"},{"rate":"0.1-1%","effect":"Stroke"},{"rate":"0.01-0.1%","effect":"Death"}]},"_chembl":{"chemblId":"CHEMBL2108760","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The procedure involves using radiofrequency energy to destroy the abnormal electrical pathways in the heart, restoring a normal heart rhythm. This is achieved through the injection of a solution that helps to visualize the heart tissue during the ablation process.","oneSentence":"ABI injection is used to treat atrial fibrillation by ablating the heart tissue causing the arrhythmia.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:47:19.901Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Atrial fibrillation for stroke prevention"},{"name":"Atrial fibrillation for symptomatic control"}]},"trialDetails":[{"nctId":"NCT04310007","phase":"PHASE2","title":"Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-07-13","conditions":"Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8","enrollment":117},{"nctId":"NCT04266249","phase":"PHASE2","title":"CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2020-03-13","conditions":"Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8","enrollment":2175},{"nctId":"NCT07481656","phase":"PHASE4","title":"Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT)","status":"NOT_YET_RECRUITING","sponsor":"Anhui Provincial Hospital","startDate":"2026-04-10","conditions":"Acute Brain Injuries, Moderate to Severe Traumatic Brain Injury","enrollment":160},{"nctId":"NCT06059118","phase":"PHASE2","title":"Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2023-10-04","conditions":"Prostate Cancer","enrollment":50},{"nctId":"NCT02495896","phase":"PHASE1","title":"Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Southern California","startDate":"2015-09-03","conditions":"Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma","enrollment":61},{"nctId":"NCT02043678","phase":"PHASE3","title":"Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms","status":"COMPLETED","sponsor":"Bayer","startDate":"2014-03-30","conditions":"Prostatic Neoplasms","enrollment":806},{"nctId":"NCT05238831","phase":"EARLY_PHASE1","title":"SMMART Adaptive Clinical Treatment (ACT) Trial","status":"WITHDRAWN","sponsor":"OHSU Knight Cancer Institute","startDate":"2023-01-30","conditions":"Advanced Breast Carcinoma, Advanced Malignant Solid Neoplasm, Advanced Ovarian Carcinoma","enrollment":""},{"nctId":"NCT04820686","phase":"PHASE2","title":"A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection","status":"TERMINATED","sponsor":"Assembly Biosciences","startDate":"2021-05-07","conditions":"Chronic Hepatitis B","enrollment":65},{"nctId":"NCT04781647","phase":"PHASE2","title":"A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus Infection","status":"TERMINATED","sponsor":"Assembly Biosciences","startDate":"2021-02-18","conditions":"Chronic Hepatitis B","enrollment":54},{"nctId":"NCT03903653","phase":"PHASE2","title":"Botulinum Toxin A & Weekly Serial Casting in ABI Inpatients With Lower Extremity Spasticity","status":"WITHDRAWN","sponsor":"Hamilton Health Sciences Corporation","startDate":"2019-09-01","conditions":"Spastic Foot","enrollment":""},{"nctId":"NCT02829502","phase":"PHASE2","title":"The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke","status":"UNKNOWN","sponsor":"Christina Kruuse","startDate":"2016-08","conditions":"Ischemic Stroke","enrollment":30},{"nctId":"NCT05240872","phase":"PHASE3","title":"Effects of Autologous Blood Injection Versus Platelet Rich Plasma on Chronic Plantar Fasciitis","status":"COMPLETED","sponsor":"Istanbul Training and Research Hospital","startDate":"2020-03-01","conditions":"Plantar Fascitis","enrollment":60},{"nctId":"NCT04746599","phase":"NA","title":"Autologous Fat Grafting in the Treatment of Critical Limb Ischaemia","status":"UNKNOWN","sponsor":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","startDate":"2021-01-01","conditions":"Critical Limb Ischemia, Peripheral Arterial Disease - PAD, Ischemic Ulcer","enrollment":20},{"nctId":"NCT04667832","phase":"","title":"ABI for Screening of Coronary Artery Disease","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","startDate":"2019-03-01","conditions":"Coronary Artery Disease","enrollment":4207},{"nctId":"NCT02546089","phase":"NA","title":"ABI v Dry Needling for Plantar Fasciitis","status":"COMPLETED","sponsor":"University Hospitals, Leicester","startDate":"2014-10","conditions":"Plantar Fasciitis","enrollment":90},{"nctId":"NCT00254592","phase":"PHASE2","title":"Neoadjuvant Treatment of Breast Cancer","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2005-10","conditions":"Breast Cancer","enrollment":43},{"nctId":"NCT02838589","phase":"PHASE2","title":"The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers","status":"COMPLETED","sponsor":"Christina Kruuse","startDate":"2016-08","conditions":"Stroke","enrollment":30},{"nctId":"NCT02864654","phase":"PHASE1, PHASE2","title":"Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia","status":"UNKNOWN","sponsor":"Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation","startDate":"2016-07","conditions":"Critical Limb Ischemia, Arteriosclerosis Obliterans, Peripheral Arterial Disease","enrollment":9}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"ABI injection","genericName":"ABI injection","companyName":"Istanbul Training and Research Hospital","companyId":"istanbul-training-and-research-hospital","modality":"Biologic","firstApprovalDate":"","aiSummary":"ABI injection is used to treat atrial fibrillation by ablating the heart tissue causing the arrhythmia. Used for Atrial fibrillation for stroke prevention, Atrial fibrillation for symptomatic control.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}